Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ofloxacin side effects in elderly with bone and joint infection
NCT04496024Recruiting
- Sponsor
- CHU Amiens-Picardie
- Start
- Jun 2020
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ofloxacin in Bone and osteoarticular infections (BJI), sponsored by CHU Amiens-Picardie. Primary endpoint: Frequency of one adverse reaction attributable to ofloxacin at 3 days. Started Jun 2020; status: recruiting.
02
Drugs
ofloxacin
03
Conditions
Bone and osteoarticular infections (BJI)
Beyond the preview
Go deeper on NCT04496024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04496024.